Laws banning smoking at workplaces and other public places are associated with a significantly lower risk of cardiovascular disease, according to a new study.
Browsing: Clinical Breakthroughs
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.
Within the Institute for Public Health and Medicine (IPHAM), investigators collaborate at the intersection of public health and medicine — connecting clinics to communities and accelerating innovations that impact the health of both patients and populations.